[ACRV] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[ACRV] Acrivon Therapeutics, Inc. Common Stock
Announcement Date
28-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -33.08%
YoY- -143.30%
Quarter Report
ACRV's Result
ACRV's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 CAGR
Revenue 1,884 0 0 -
PBT -19,252 -8,929 -4,343 110.54%
Tax 1,770 -1,016 73 392.40%
NP -19,252 -7,913 -4,416 108.79%
Tax Rate - - - -
Total Cost 21,136 7,913 4,416 118.77%
Ratio Analysis
31/12/23 31/12/22 31/12/21 CAGR
NP Margin -1,021.87 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 CAGR
EPS -0.86 -0.38 -0.34 59.04%
EPS Diluted -0.86 -0.38 -0.34 59.04%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.